Researchers from the Oswaldo Cruz Institute (IOC/Fiocruz) identified 35 small molecules capable of binding to an important protein of the Schistosoma mansoni parasite
It should expand surveillance beyond Sars-CoV-2, coordinating global efforts for early detection and evaluation of other coronaviruses
Participants discussed topics such as research, production, clinical studies, regulatory issues and registration of biological products
The new antigen produced can be added to the rapid serological test used in the Brazilian Public Health System (SUS). Currently, there is no national product with this efficacy
Subscribe and receive our news via email